The effect of statin [HMG CoA reductase inhibitor] use on vascular function in hypertensive subjects.

Trial Profile

The effect of statin [HMG CoA reductase inhibitor] use on vascular function in hypertensive subjects.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 May 2010

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 May 2010 Procris Pharmaceuticals added as trial sponser as reported by ClnicalTrial.gov record.
    • 27 May 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.
    • 27 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top